Millennium
Laboratories, Inc., a leading provider of therapeutic drug
monitoring and education to physicians and staff treating chronic pain
patients, today announced the company’s support for a recent decision by
the Florida Pain Management Clinic Standards of Practice Joint Committee
to amend draft regulatory language related to the certification of
clinical laboratories providing services to pain physicians operating in
the state.
“By recognizing that the SAMHSA standard would
have made clinical lab testing for Florida doctors decidedly more
difficult and then acting accordingly, the committee should be credited
for its decision. The vote to reverse this proposed language reflects
awareness and flexibility that should be highly commended.”
Voting unanimously, the committee agreed January 23rd to alter a
proposed state rule by requiring clinical labs providing services in
Florida to be certified through the federal Clinical Laboratory
Improvement Amendments (CLIA) program. As originally written the draft
rule would have required Substance
Abuse and Mental Health Services (SAMHSA) certification, a program
narrowly focused and intended for use with illicit drug abuse versus the
abuse of controlled medications.